Dexamethasone + Punctum Plug
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 34/100
34
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post Ocular Surgical Inflammation and Pain
Conditions
Post Ocular Surgical Inflammation and Pain
Trial Timeline
Feb 1, 2014 → Feb 1, 2015
NCT ID
NCT02034019About Dexamethasone + Punctum Plug
Dexamethasone + Punctum Plug is a phase 3 stage product being developed by Ocular Therapeutix for Post Ocular Surgical Inflammation and Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02034019. Target conditions include Post Ocular Surgical Inflammation and Pain.
What happened to similar drugs?
20 of 20 similar drugs in Post Ocular Surgical Inflammation and Pain were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02034019 | Phase 3 | Completed |
Competing Products
20 competing products in Post Ocular Surgical Inflammation and Pain